Article Text
Abstract
Neurologists increasingly care for people with significant frailty in both clinic and ward settings. Such care demands a balanced approach to investigation, diagnosis and treatment, as well-intentioned actions can produce adverse effects. This article presents a practical approach to the identification and management of patients with frailty and neurological conditions. We address medicines optimisation, common causes of deterioration in those with frailty, communication, decisions about intensity of treatment, and shared decision-making including ethical aspects of withholding or withdrawing life-prolonging treatment, with a view to improving the experience both of people living with frailty and of the teams who care for them.
- clinical neurology
Statistics from Altmetric.com
Footnotes
Twitter @lucypgeridoc
Contributors LP and MS wrote the article.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Commissioned. Externally peer reviewed by Susan White, Cardiff, UK, and John Thorpe, Cambridge, UK.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Linked Articles
- Editors’ commentary
- Editorial
Read the full text or download the PDF:
Other content recommended for you
- Neurological and cognitive impairments detected in older people without a diagnosis of neurological or cognitive disease
- Frailty degree and illness trajectories in older people towards the end-of-life: a prospective observational study
- ‘Under pressure’: is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?
- A key role for comprehensive geriatric assessment in aortic valve replacement
- Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies
- Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy
- Neuropsychiatric non-motor aspects of Parkinson’s disease
- Efficacy of nurse-led and general practitioner-led comprehensive geriatric assessment in primary care: protocol of a pragmatic three-arm cluster randomised controlled trial (CEpiA study)
- Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations
- Plasma α-synuclein predicts cognitive decline in Parkinson’s disease